WHO ICTRP trial
Comparison the amoxicillin and pantoprazole regimen with quadruple regimen for…
IRCT20211019052812N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20211019052812N1 |
|---|---|
| Public title | Comparison the amoxicillin and pantoprazole regimen with quadruple regimen for Helicobacter pylori eradication |
| Scientific title | Comparison of the efficacy of the amoxicillin and pantoprazole regimen with clarithromycin-based quadruple regimen for Helicobacter pylori eradication |
| Primary sponsor | Ahvaz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Helicobacter pylori infection. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere;B96.81 |
| Interventions | Intervention 1: Intervention group: (dual regimen): amoxicillin 1000 mg every 12 hours (Farabi pharmaceutical CO., Iran) and pantoprazole 40 mg every 12 hours (Tehranchemie CO., Iran) for 14 days and then pantoprazole 40 mg every 12 hours… |
| Registration date | Nov 6, 2021 |
| Target size | 166 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: